Quality of life in patients with metastatic colorectal cancer receiving cytotoxic and cytotoxic plus targeted therapy
Compared with those on CyT alone, patients with mCRC receiving Cy-TaT showed improved overall H/QoL, functional scales, and symptom scales/items. These benefits were consistent across most subgroups of chemotherapy, with the greatest improvements in H/QoL observed in the CAPEOX-TaT and mFOLFOX-7-TaT groups.
Authors
- Ronald Lynel Castelino (ORCID: https://orcid.org/0000-0002-5128-7115)
- Hong Tham Pham (ORCID: https://orcid.org/0000-0002-2366-629X)
- Vy Tran (ORCID: https://orcid.org/0009-0007-0516-7191)
- Minh‐Hoang Tran (ORCID: https://orcid.org/0000-0003-1351-8442)
- Việt Dũng Trần (ORCID: https://orcid.org/0000-0002-3598-5829)
- Matthias Fischer (ORCID: https://orcid.org/0000-0003-4728-8497)
- Tuan Anh Nguyen (ORCID: https://orcid.org/0000-0002-3554-2526)
- Kim‐Huong Truong‐Nguyen (ORCID: https://orcid.org/0009-0004-6503-2756)
- Bao Khanh Nguyen
- Threatt Ba
Institutions
- Nha Trang University (VN)
- University of Colorado Hospital (US)
- The University of Sydney (AU)
- National Economics University (VN)
- Blacktown & Mount Druitt Hospital (AU)
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- Trường ĐH Nguyễn Tất Thành (VN)
- University of Khanh Hoa (VN)
- Pham Ngoc Thach Hospital (VN)
- University of Colorado Denver (US)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1186/s12885-025-14388-2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00